cereblon E3 ligase modulators
Vulnerabilities in lipid synthesis pathways and resistance to IMiDs and CELMoDs in multiple myeloma
Sarah Bird • 9 Dec 2022
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.